HR Execs on the Move

Innocrin Pharmaceuticals

www.innocrinpharma.com

 
Innocrin discovers and develops novel, best-in-class oral inhibitors of CYP17 lyase, a validated enzyme target for the treatment of castration-resistant prostate cancer (CRPC). VT-464 and structurally-related classes of CYP17 inhibitors are wholly owned by Innocrin. CYP17 lyase inhibitors may also have high commercial potential for the treatment of breast cancer as well as non-oncologic syndromes that are due to hormonal excess including endometriosis, polycystic ovary syndrome and congenital adrenal hyperplasia.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Site Management Solutions

Site Management Solutions is a Glen Burnie, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Merchandise

Merchandise Incorporated is a Miamitown, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MacroCap Labs

MacroCap Labs is a contract manufacturing company founded in 2010. With steady improvements in quality and capacity, we have become one of the top contract manufacturers in the state of Florida. Our FDA registered facility ensures that we meet or excee...

Development Chemicals

Development Chemicals is a Atlantic Highlands, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cobalt Pharmaceuticals

Cobalt Pharmaceuticals Inc. is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.